Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-05-15

Clinical Trial Update: Evaluation of the Pharmacokinetic Profile, Pharmacodynamic Effects, Acceptability and Tolerability of an Oral Amiodarone Solution of 15 mg / mL in Children With Supra Ventricular Tachycardia [Phase 2]

View source ↗

Summary

A Phase 2 pediatric trial evaluating the pharmacokinetic, pharmacodynamic, acceptability, and tolerability of an oral amiodarone solution in children with supra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amiodarone (amiodarone)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Supraventricular Tachycardia | Phase 2 | Status: WITHDRAWN